definiens: shall mean the A ventis CRF I Compound Technology and [COMPANY] CRF1 Receptor Technology, each as defined below . Notwithstanding any other provision of this Agreement, it is understood and agreed to by the Parties that the [COMPANY] Contributed Technology does not include any of [COMPANY] ' proprietary screening, pharmaceutical development, regulatory or commercialization Technology that is not specific to CRF1• ( a ) shall mean . all Technology ( other than Joint Technology ) owned or Controlled by A ventis on the Effective Date or during the Research Program, which ( i ) is, relates specifically to, claims or describes any A ventis Compound that qualifies as an Active Compound or ( ii ) that is particular to CRF I Receptor Antagonist ! Agonists and is necessary to research, develop, make, use or sell any A ventis Compound, [COMPANY] Compound, or Joint Compound that qualifies as an Active Compound